Oklahoma Cityís pioneering spirit shows up in the futuristic achievements of the regionís biotech industry. From its foundations until today, see how synergy, discovery and sharing Oklahoma Cityís bioscience industry with the world has made the region a frontier for achievement.
With this multimillion-dollar NCI grant, the Stephenson Cancer Center continues its status as a Lead Academic Participating Site in the National Clinical Trials Network.
The funding will support laboratory projects as well as clinical studies to help Oklahomans suffering from conditions such as multiple sclerosis and lupus.
44 years after its founding, the Dean McGee Eye Institute is on the cutting edge of eye care.
More than 40 Oklahoma bioscience and industry experts from a wide array of fields are busy telling global industry leaders about the stateís successes in the bioscience sector.
A $34 million dollar gift made to the Harold Hamm Diabetes Center by The Harold Hamm Foundation is the largest gift ever made to the HHDC.
A physician-scientist at Stephenson Cancer Center at OU Medicine co-directed an international clinical trial that yielded findings considered unprecedented in the field of gynecological cancer.
Gallogly: Intellectual property development will fuel Innovation District growth